Skip to main content

Together we are beating cancer

Donate now

Cancer type

Showing 12 out of 2908 results
3D rendering of oesophageal cancer

The Scottish Medicines Consortium (SMC) has approved the immunotherapy drug nivolumab (Opdivo) for some patients with advanced oesophageal cancer. The Scottish Medicines Consortium (SMC) has approved the immunotherapy drug nivolumab (Opdivo) for some patients with advanced oesophageal cancer.

by Harry Jenkins | News | 11 August 2021

11 August 2021

A transgender woman in a hospital gown speaking to her doctor, a transgender man, in an exam room.

LGBTQIA+ communities experience inequalities throughout their cancer journey, including in screening and diagnosis, clinical care, communication and overall experience. Find out about the barriers the community faces and the commitments required to improve cancer care for LGBTQIA+ people. LGBTQIA+ communities experience inequalities throughout their cancer journey, including in screening and diagnosis, clinical care, communication and overall experience. Find out about the barriers the community faces and the commitments required to improve cancer care for LGBTQIA+ people.

by Harry Jenkins | Analysis | 26 July 2021

26 July 2021

Medical technologist holding urine tube test in medical laboratory

Cancer Research UK scientists are developing tests that can detect the presence of glioma, a type of brain tumour, in patient urine or blood plasma. Cancer Research UK scientists are developing tests that can detect the presence of glioma, a type of brain tumour, in patient urine or blood plasma.

by Cancer Research UK | News | 23 July 2021

23 July 2021

The National Institute of Health and Care Excellence (NICE) has approved the use of pemigatinib in adults with a rare type of bile duct cancer that has continued to advance or spread after initial chemotherapy. The National Institute of Health and Care Excellence (NICE) has approved the use of pemigatinib in adults with a rare type of bile duct cancer that has continued to advance or spread after initial chemotherapy.

by Harry Jenkins | News | 22 July 2021

22 July 2021

A new study is looking at how blood tests after cancer surgery can be used to select patients for additional treatment, potentially sparing some patients from unnecessary, often toxic, treatment whilst ensuring those who need it get it as early as possible. A new study is looking at how blood tests after cancer surgery can be used to select patients for additional treatment, potentially sparing some patients from unnecessary, often toxic, treatment whilst ensuring those who need it get it as early as possible.

by Harry Jenkins | Analysis | 14 July 2021

14 July 2021

Woman refuses more red wine

1 in 25 newly diagnosed cancer cases in the last year may be associated with drinking alcohol, according to a global study published in The Lancet Oncology. 1 in 25 newly diagnosed cancer cases in the last year may be associated with drinking alcohol, according to a global study published in The Lancet Oncology.

by Harry Jenkins | News | 14 July 2021

14 July 2021

antibodies

How scientific expertise, funding and entrepreneurship came together for the development of an antibody-drug conjugate targeting lymphoma. How scientific expertise, funding and entrepreneurship came together for the development of an antibody-drug conjugate targeting lymphoma.

by Cancer Research UK | Research Feature | 2 July 2021

2 July 2021

doctor holding urine sample

The University of Birmingham has partnered with Nonacus, a company that develops non-invasive genetic testing devices, to produce a urine test for bladder cancer that could spare thousands of people invasive procedures. The University of Birmingham has partnered with Nonacus, a company that develops non-invasive genetic testing devices, to produce a urine test for bladder cancer that could spare thousands of people invasive procedures.

by Harry Jenkins | News | 2 July 2021

2 July 2021

Researcher in a lab

A study led by The Institute of Cancer Research, part-funded by Cancer Research UK, finds genetic changes in children with rare cancer could help tailor treatment. A study led by The Institute of Cancer Research, part-funded by Cancer Research UK, finds genetic changes in children with rare cancer could help tailor treatment.

by Cancer Research UK | News | 28 June 2021

28 June 2021